scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCP.20013 |
P698 | PubMed publication ID | 15137061 |
P2093 | author name string | Ming Zhou | |
He Huang | |||
Jian Ma | |||
Jie Zhou | |||
Wei Xiong | |||
Gui-Yuan Li | |||
Shou-Rong Shen | |||
Xiao-Ling Li | |||
Bi-Cheng Zhang | |||
Shi-Guo Zhu | |||
Hua-Ying Liu | |||
P2860 | cites work | Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4 | Q24314643 |
BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19) | Q24685696 | ||
Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals | Q40023280 | ||
P433 | issue | 1 | |
P304 | page(s) | 89-98 | |
P577 | publication date | 2004-07-01 | |
P1433 | published in | Journal of Cellular Physiology | Q1524270 |
P1476 | title | BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways | |
P478 | volume | 200 |
Q46493497 | A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7). |
Q34585861 | A sex-specific role of type VII adenylyl cyclase in depression. |
Q33247289 | BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis |
Q36118557 | BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma |
Q51416712 | BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141. |
Q55119106 | BRD7 inhibits the Warburg effect and tumor progression through inactivation of HIF1α/LDHA axis in breast cancer. |
Q24303120 | BRD7 is a candidate tumour suppressor gene required for p53 function |
Q38760091 | BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-кB signaling pathway |
Q33838482 | BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K |
Q47414450 | BRD7 regulates the insulin-signaling pathway by increasing phosphorylation of GSK3β. |
Q48079928 | BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways |
Q37731459 | BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity |
Q26751298 | BRD7: a novel tumor suppressor gene in different cancers |
Q38788315 | Biological function and histone recognition of family IV bromodomain-containing proteins |
Q35120841 | Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes |
Q37086000 | Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma |
Q24308923 | Ceap/BLOS2 interacts with BRD7 and selectively inhibits its transcription-suppressing effect on cellular proliferation-associated genes |
Q25255613 | Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results |
Q54933469 | Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains |
Q37431423 | Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. |
Q38457229 | Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network |
Q34514258 | Knockout of BRD7 results in impaired spermatogenesis and male infertility |
Q27704896 | NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains |
Q34611577 | Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis |
Q36810352 | Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments |
Q89944401 | Oral Exposure to Genistein during Conception and Lactation Period Affects the Testicular Development of Male Offspring Mice |
Q92800638 | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents |
Q36662249 | Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus |
Q54280630 | Prognostic relevance of BRD7 expression in colorectal carcinoma. |
Q33367808 | Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells |
Q35641383 | Retracted: Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7 |
Q37260036 | Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. |
Q53280723 | TRIM proteins and cancer. |
Q24316908 | TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells |
Q33917573 | Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma |
Q39455273 | The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma |
Q38264787 | The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma |
Q37117156 | The role of BRD7 in embryo development and glucose metabolism |
Q24293463 | The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain |
Q33396101 | Transcriptional regulation of BRD7 expression by Sp1 and c-Myc |
Q42009542 | Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses |
Q55449419 | [Expression and clinical significance of bromodomain-containing protein 7 in non-small cell lung cancer]. |
Q36775043 | miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma |
Q39755104 | microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network |
Q24685269 | LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathw |
Search more.